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Background
The Cancer Stem Cells (CSCs) hypothesis proposes that
malignant brain tumours are organized into aberrant
cell hierarchies where a subset of parent CSCs replicate
asymmetrically and unlimitedly to produce differentiated
daughter cell [1,2]. These parent CSCs are highly adap-
tive and resistant to the chemotherapeutic drugs [3].
Developing new drugs that target CSCs requires a com-
prehensive understanding of the pharmacogenomics
behavior of these cells [4,5]. Such understanding
requires reliable in vitro and in vivo models that repre-
sent the beneficial patients. This project is set out to: i)
Establish a collection of astrocytoma cell lines generated
from Saudi patients, ii) Select drug resistant brain
tumour CSCs, iii) Characterize drug resistant brain
tumour CSCs individually, and iv) Deduce common fea-
tures for drug resistant brain tumour CSCs.
Materials and methods
A range of methodologies will be applied including,
tumour cell line derivation methods, the clonogenic selec-
tion assay, cytogenetics profiles, neuronal cancer stem
cells characterisation assays and in vivo tumourgenic
assays.
Results
Optimisation of methods used to establish astrocytoma
cell lines generated from Saudi patients was completed.
To date two novel primary astrocytoma cell lines have
been derived. Full clinical data related to the cell lines
was retrieved. Currently, optimisation of the clonogenic
selection assay and immunostaining for cancer stem
cells markers are under progress.
Conclusions
Successful retrieval of primary astrocytoma cell lines was
possible to accomplish. Important clinical information
data relevant to the cell lines were obtained providing
clear identification reference. Further work is required for
the characterization of the drug resistant cancer stem cell
component within these cell lines. Once completed, this
research will assist in understanding some of the molecu-
lar mechanisms relevant to drug resistance, especially for
patients in the Kingdom of Saudi Arabia.
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